US Patent 7772201 Highly branched HK peptides as effective carriers of siRNA
Patent 7772201 was granted and assigned to University of Maryland, Baltimore on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+567 characters)
Article
Patent abstract
The present invention is directed to methods of transfecting cells with siRNA, by contacting a transfection complex with one or more cells, where the transfection complex includes a transport polymer and siRNA. The transport polymer may include for example, H3K8b and/or structurally similar compounds. The invention is also directed to such transfection complexes, and to compositions that include such transfection complexes. The invention is further directed to methods of treating patients using the transfection complexes of the present invention.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Archibald Mixson0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07772201 Highly branched HK peptides as effective carriers of siRNA US Patent 7772201 Highly branched HK peptides as effective carriers of siRNA
Infobox
Patent Number
07772201
Patent Number
7772201
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07772201 Highly branched HK peptides as effective carriers of siRNA
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07772201
Date of patent
August 10, 2010
Patent application number
11718342
Date Filed
November 17, 2005
Patent primary examiner
Find more entities like US Patent 7772201 Highly branched HK peptides as effective carriers of siRNA
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.